Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Toxicology
|
June 4, 2013
Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation
Thitirat Ngaotepprutaram, Barbara L F Kaplan, Stephen Carney, et al.
Methods in Enzymology
|
January 18, 2020
Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models
Mahmoud S Alghamri, Felipe J Núñez, Neha Kamran, et al.
Trends in Cancer
|
October 11, 2024
Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications
Santiago Haase, Stephen Carney, Maria Luisa Varela, et al.
Expert Opinion on Therapeutic Targets
|
June 12, 2018
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase, María Belén Garcia-Fabiani, Stephen Carney, et al.
Neuro-Oncology
|
February 21, 2020
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease
Flor M Mendez, Felipe J Núñez, Maria B Garcia-Fabiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2020
Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Flor Mendez, Padma Kadiyala, Felipe J Nunez, et al.
Expert Opinion on Investigational Drugs
|
May 14, 2020
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development
Maria B Garcia-Fabiani, Maria Ventosa, Andrea Comba, et al.
Expert Opinion on Biological Therapy
|
January 22, 2020
Prospects of biological and synthetic pharmacotherapies for glioblastoma
David B Altshuler, Padma Kadiyala, Felipe J Nuñez, et al.
Frontiers in Oncology
|
June 25, 2021
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
Maria B Garcia-Fabiani, Santiago Haase, Andrea Comba, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Toxicology
|
June 4, 2013
Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation
Thitirat Ngaotepprutaram, Barbara L F Kaplan, Stephen Carney, et al.
Methods in Enzymology
|
January 18, 2020
Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models
Mahmoud S Alghamri, Felipe J Núñez, Neha Kamran, et al.
Trends in Cancer
|
October 11, 2024
Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications
Santiago Haase, Stephen Carney, Maria Luisa Varela, et al.
Expert Opinion on Therapeutic Targets
|
June 12, 2018
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase, María Belén Garcia-Fabiani, Stephen Carney, et al.
Neuro-Oncology
|
February 21, 2020
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease
Flor M Mendez, Felipe J Núñez, Maria B Garcia-Fabiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2020
Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Flor Mendez, Padma Kadiyala, Felipe J Nunez, et al.
Expert Opinion on Investigational Drugs
|
May 14, 2020
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development
Maria B Garcia-Fabiani, Maria Ventosa, Andrea Comba, et al.
Expert Opinion on Biological Therapy
|
January 22, 2020
Prospects of biological and synthetic pharmacotherapies for glioblastoma
David B Altshuler, Padma Kadiyala, Felipe J Nuñez, et al.
Frontiers in Oncology
|
June 25, 2021
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
Maria B Garcia-Fabiani, Santiago Haase, Andrea Comba, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Page
of 2